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Abstract: The neurosteroids allopregnanolone and dehydroepiandrosterone (DHEA) are integral components
of the stress response and exert positive modulatory effects on emotion in both human and animal studies.
Although these antidepressant and anxiolytic effects have been well established, to date, little research has
examined their neural correlates, and no research has been conducted into the effects of neurosteroids on
large-scale networks at rest. To investigate the neurosteroid impact on intrinsic connectivity networks, partici-
pants were administered 400 mg of pregnenolone (N5 16), 400 mg of DHEA (N5 14), or placebo (N5 15)
and underwent 3T fMRI. Resting-state brain connectivity was measured using amygdala as a seed region.
When compared with placebo, pregnenolone administration reduced connectivity between amygdala and
dorsal medial prefrontal cortex, between amygdala and precuneus, and between amygdala and hippocampus.
DHEA reduced connectivity between amygdala and periamygdala and between amygdala and insula. Reduc-
tions in amygdala to precuneus connectivity were associated with less self-reported negative affect. These
results demonstrate that neurosteroids modulate amygdala functional connectivity during resting state and
may be a target for pharmacological intervention. Additionally, allopregnanolone and DHEA may shift the
balance between salience network and default network, a finding that could provide insight into the neurocir-
cuitry of anxiety psychopathology. Hum Brain Mapp 35:3249–3261, 2014. VC 2013Wiley Periodicals, Inc.
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INTRODUCTION
Allopregnanolone and dehydroepiandrosterone (DHEA)
are endogenously produced neurosteroids with neuropro-
tective, anxiolytic, antidepressant, antioxidant, and antiglu-
cocorticoid effects [Belelli and Lambert, 2005; Maninger
et al., 2009; Patchev et al., 1994]. Deficiencies in allopregna-
nolone and DHEA are related to anxiety and depressive-
like behavior. For instance, endogenous levels of allopreg-
nanolone and DHEA are decreased in animal models of
depression, and these animals exhibit behavioral improve-
ments after DHEA administration or allopregnanolone
induction [Genud et al., 2009; Pibiri et al., 2008]. DHEA
and allopregnanolone administration reduce immobility in
the forced swim test [Frye et al., 2004; Urani et al., 2001]
and reduce stress and anxiety-like behavior in rodents
[Frye and Rhodes, 2006; Melchior and Ritzmann, 1994]. In
human studies, allopregnanolone and DHEA dysregula-
tion is associated with anxiety and depression. Individuals
with major depressive disorder exhibit reduced plasma
and cerebrospinal fluid (CSF) levels of allopregnanolone
[Romeo et al., 1998; Uzunova et al., 1998] and DHEA [Bar-
rett-Connor et al., 1999; Morsink et al., 2007; Wong et al.,
2011], and those with post traumatic stress disorder
(PTSD) show reduced CSF allopregnanolone [Rasmusson
et al., 2006]. Furthermore, increases in serum allopregna-
nolone and DHEA over a course of treatment predict
symptomatic improvement [Amin et al., 2006; Olff et al.,
2007; Uzunova et al., 1998; Yehuda et al., 2006]. Therefore,
these neurosteroids show promise as targets for antide-
pressant and anxiolytic effects in psychiatric disorders.
Converging preclinical and neuroimaging research sug-
gests that the amygdala, a key region in threat detection
[Adolphs et al., 1999], fear conditioning [Armony and
LeDoux, 1997], and emotional salience [Whalen et al.,
2001], may be a particular locus of allopregnanolone and
DHEA’s effects. Our laboratory has recently demonstrated
that single-dose DHEA [Sripada et al., 2013a] and the allo-
pregnanolone precursor pregnenolone [Sripada et al.,
2013b] decrease amygdala activity and increase activity in
medial prefrontal regions during tasks engaging cogni-
tion–emotion interactions. It had been reported that pro-
gesterone administration (which in turn increases
allopregnanolone levels) modulates amygdala responsivity
to emotional faces [van Wingen et al., 2007] and increases
functional connectivity between amygdala and dorsal
medial prefrontal cortex (dmPFC) [van Wingen et al.,
2008]. Allopregnanolone modulates GABA(A) receptor-
mediated inhibitory postsynaptic currents in the central
nucleus of the amygdala [Wang et al., 2007], and microin-
fusions of allopregnanolone directly into the amygdala
produce anxiolytic [Engin and Treit, 2007] and antidepres-
sant [Shirayama et al., 2011] effects. The anxiolytic and
antidepressant effects of DHEA may be mediated by the
amygdala as well. In animal models, DHEA administra-
tion increases BDNF concentration [Naert et al., 2007] and
5-HT(2A) receptor expression [Cyr et al., 2000] in the
amygdala, and DHEA infusions into the amygdala modu-
late stress responsivity [Singh et al., 1994]. Thus, the amyg-
dala might be a key region in the anxiolytic and emotion
modulatory effects of neurosteroids.
Although mounting evidence suggests that neurosteroids
modulate amygdala activity, the reported direction of
amygdala modulation is somewhat inconsistent. Activation
of amygdala has been reported as increased [van Wingen
et al., 2008] or decreased [Sripada et al., 2013b; van Wingen
et al., 2007] by allopregnanolone depending on the task
used. To fully understand the impact of neurosteroids on
amygdala function, it may be necessary to examine their
effects on amygdala connectivity at rest. Resting-state con-
nectivity offers a powerful way to assess intrinsic connec-
tions between brain networks [Fox and Raichle, 2007; Fox
et al., 2005; Raichle et al., 2001] without external demands
or confounds imposed by specific tasks. The amygdala
resting-state network encompasses regions associated with
emotion generation, including ventral medial prefrontal cor-
tex, insula, thalamus, and striatum [Fulwiler et al., 2012;
Kim et al., 2011; Roy et al., 2009]. Thus, resting-state analy-
ses may provide a fuller understanding of neurosteroid
modulation of the amygdala and its associated emotion
production network. Previous investigations demonstrate
that the amygdala is strongly positively correlated with
contralateral amygdala and insula at rest and strongly anti-
correlated with precuneus [Kim et al., 2011; Roy et al.,
2009]. Because of their anxiolytic and antidepressant prop-
erties, we predicted that allopregnanolone and DHEA
would modulate both positive (amygdala and insula) and
negative (precuneus) connectivity within the amygdala
functional connectivity network during rest [Roy et al.,
2009] and that this effect would be associated with reduced
self-reported negative affect. Furthermore, given the impact
of allopregnanolone and DHEA on functional connectivity
between amygdala and mPFC [Alhaj et al., 2006; Sripada
et al., 2013a,b; van Wingen et al., 2008], we hypothesized
that these neurosteroids would also modulate resting-state
amygdala connectivity with mPFC.
MATERIALS AND METHODS
Participants
Study participants were 45 right-handed healthy male
volunteers aged 18–34 years (mean6 SD5 226 3.6)
recruited from the community via advertisement. Exclu-
sion criteria were a history of head injury, recent steroid
use, or current or past psychiatric disorder, as assessed via
the Mini-International Neuropsychiatric Interview [Shee-
han et al., 1998]. No participant was taking over-the-
counter or prescription medication at the time of the
experiment. Participants were given full details of the
study and provided written informed consent. The study
was approved by the Institutional Review Board of the
University of Michigan Medical School.
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Procedure
To control for any potential diurnal variation in endoge-
nous DHEA [Stanczyk, 2006], all functional magnetic reso-
nance imaging (fMRI) scans were conducted in the
afternoon, and blood collection times were standardized
across subjects. Baseline blood samples were drawn
between 11:00 and 11:30 a.m., and postscan blood samples
were drawn between 3:00 and 4:00 p.m. At 1-h postdrug
administration, participants completed the Positive and
Negative Affect Scale Expanded (PANAS-X) [Watson and
Clark, 1994], the Drug Effects Questionnaire [Morean
et al., 2013], and a 20-item Visual Analog Scale. The Drug
Effects Questionnaire assessed the extent to which partici-
pants (1) felt any substance effects, (2) liked the effects, (3)
felt high, and (4) wanted more of the substance. The Vis-
ual Analog Scale included the following items: Clear-
headed, Anxious, Stimulated, Tired, Calm, Drowsy, Peace-
ful, Nervous, Hungry, Energetic, Uneasy, Relaxed, Alert,
Contented, Focused, Dreamy, Restless, Nauseous, Worn
Out, and Jittery. Each item consisted of a 4-inch bar with
“Not At All” and “Extremely” indicated at the extremities.
Drug Administration
Study drugs (pregnenolone and DHEA) and matching
placebo identical in appearance were obtained from Belmar
Pharmacy (Lakewood, CO), which provided certificates of
analysis. Participants were randomly assigned to receive a
single oral dose of 400 mg pregnenolone, 400 mg DHEA, or
placebo. Participants and investigators were blind to condi-
tion. Pregnenolone was administered as a precursor loading
strategy to significantly increase downstream allopregnano-
lone levels. Although data are limited, allopregnanolone
serum levels appear to reach three times baseline levels in 2
h after oral administration of 400 mg pregnenolone (Marx,
unpublished data), and DHEA serum concentrations peak
60 to 480 min after DHEA administration [Arlt et al., 1998].
Thus, drug administration occurred 2 h before neuroimag-
ing to ensure elevated levels during the scan.
Steroid Measurements
We used circulating levels of DHEA and allopregnano-
lone as indicators of central neurosteroid levels. In animal
models, serum pregnenolone levels are closely related to
levels in the hippocampus [Marx et al., 2006a], and serum
DHEA levels are closely related to levels in CSF [Kancheva
et al., 2011], although Kancheva and colleagues did not
find a correlation between CSF and serum pregnenolone
levels. CSF DHEA levels are also correlated with temporal
cortex DHEA levels, as are CSF and temporal cortex preg-
nenolone levels [Naylor et al., 2008]. We collected serum
samples for assay once prior to drug administration and
once after the scanning session. Serum DHEA levels were
determined via enzyme immunoassay (ALPCO Diagnos-
tics, Salem, NH), and serum DHEAS levels were deter-
mined by chemiluminescent enzyme immunoassay
(IMMULITE) according to the manufacturer’s directions
(Siemens Healthcare Diagnostics, Tarrytown, NY). Preg-
nenolone, pregnanolone, allopregnanolone, and androste-
rone levels in serum were determined by a highly
sensitive and specific gas chromatography–mass spectrom-
etry (GC/MS) method, as previously described [Marx
et al., 2006b,c], with modifications (the electron impact
mode was used rather than negative ion chemical ioniza-
tion). One milliliter of serum was extracted three times in
ethyl acetate before high-performance liquid chromatogra-
phy purification using tetrahydrofuran, ethanol, and hex-
ane in the mobile phase. All samples were injected in
duplicate. Mean intra-assay coefficients of variation for
pregnenolone and allopregnanolone were 0.9 and 2.9%,
respectively. The limit of detection with this method was 1
pg. All neurosteroid values were natural log transformed
prior to analyses.
Resting-State Paradigm
Participants underwent structural (sMRI) and functional
(fMRI) scanning that included both an emotion regulation
task [Sripada et al., 2013a,b] and resting-state procedures.
Resting-state scans always occurred prior to tasks. Partici-
pants were positioned in the MR scanner and their heads
comfortably restrained to reduce head movement. Heart
rate and respiration measurements were acquired for
group comparisons (via Independent-Samples Kruskal-
Wallis tests). A black fixation cross on a white background
was displayed in the center of the screen for 8 min. Partici-
pants were instructed to relax and keep their eyes open
and fixed on the cross.
Image Acquisition
MRI scanning occurred on a Philips 3.0 Tesla Achieva
X-series MRI (Philips Medical Systems). After a T1 image
(T1-overlay) was obtained, a T2*-weighted, echoplanar
acquisition sequence [GRE; repetition time, 2,000 ms; echo
time, 25 ms; flip angle, 90; field of view (FOV), 22 cm; 42
slice; thickness/skip, 3.0/0 mm matrix size equivalent to
64 3 64] was collected. After discarding three initial vol-
umes to permit thermal equilibration of the MRI signal,
240 volumes were acquired over 8 min. After acquiring
the functional volumes, a high-resolution T1 scan was
obtained for anatomic normalization [26 FOV; thickness/
skip, 1.0/0 mm]. Participants viewed a fixation cross
through MR-compatible liquid crystal display goggles
(NordicNeuroLabs; http://www.nordicneurolab.com).
Preprocessing
A standard series of processing steps was performed
using statistical parametric mapping (SPM8; www.fil.io-
n.ucl.ac.uk/spm). Scans were reconstructed, motion-
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corrected, slice-time corrected, realigned to the first scan in
the experiment to correct for head motion, and coregis-
tered with the high-resolution sagittal images. Normaliza-
tion was performed using the voxel-based morphometry
toolbox implemented in SPM8 (www.fil.ion.ucl.ac.uk/
spm). Scans were normalized to standard space, seg-
mented into tissue types, bias-corrected, and iteratively
realigned using DARTEL. Smoothing was performed with
an 8 3 8 3 8 mm3 kernel. Motion parameters (mean dis-
placement and mean angle) were compared across drug
conditions via Independent-Samples Kruskal-Wallis tests,
and runs with any movement greater than 3 mm were
excluded.
Data Analysis
Right and left amygdala seed regions of interest (ROI)
were constructed from cytoarchitectonically determined
probabilistic maps of the human basolateral and centrome-
dial amygdala, developed by Amunts et al. [2005] within
the SPM Anatomy Toolbox [Eickhoff et al., 2005]. These
subregions were combined to form a single, whole amyg-
dala seed. We extracted the spatially averaged time series
from right and left amygdala ROI for each participant. As
resting-state functional connectivity measures low-
frequency spontaneous BOLD oscillations (0.01- to 0.10-Hz
band) [Fox et al., 2005], the time course for each voxel was
band-passed filtered in this range. Next, motion scrubbing
and nuisance regression were performed. During motion
scrubbing, individual frames with excessive head motion
were censored from the time series, following Power et al.
[2012]. The target high-motion frame, but not those flank-
ing it, was removed in accordance with the findings of Sat-
terthwaite et al. [2013]. Nuisance regression was
performed to remove the effects of nuisance variables
unrelated to neuronal activity. Covariates of no interest
included six motion regressors generated from the realign-
ment step noted above. In addition, we included five prin-
cipal components of the BOLD time series extracted from
white matter and CSF masks, which has been demon-
strated to effectively remove signals derived from the car-
diac and respiratory cycle [Chang and Glover, 2009]. This
method is comparable with the COMPCOR method and is
complementary to the RETROICOR method [Behzadi
et al., 2007]. In generating the white matter and CSF
regressors, subject-specific masks were first created using
VBM-based segmentation implemented in SPM8. Masks
were eroded using FSL-Erode to eliminate border regions
of potentially ambiguous tissue type. A spatially averaged
time series was extracted from these masks, and the first
five principal components were included in the regression.
The residuals from this regression were then retained for
further analysis. We did not perform global signal regres-
sion, as it had been suggested that this may produce spu-
rious anticorrelation with orthogonal networks that
increase in proportion to the size of those networks
[Anderson et al., 2011]. Pearson’s product–moment corre-
lation coefficients were calculated between average time
courses in the seed ROI and all other voxels of the brain
resulting in a three-dimensional correlation coefficient
image (r-image). These r-images were then transformed to
Z-scores using a Fisher r-to-z transformation.
Whole Brain and ROI Analysis
The Z-score images from the individual functional con-
nectivity analyses were entered into second-level random-
effects analyses (one-sample and two-sample t-tests)
implemented in SPM8. At the second level, for between-
group comparisons, we set a whole-brain voxel-wise sig-
nificance threshold at P< 0.05, cluster-level corrected for
multiple comparisons across the entire brain (cluster vol-
ume> 1,220 voxels); these cluster-level thresholds were
calculated using Monte-Carlo simulations (AFNI Alpha-
Sim; http://afni.nimh.nih.gov/afni/doc/manual/Alpha-
Sim). To exclude a general effect of drug administration
on the BOLD response [van Wingen et al., 2007], the pri-
mary visual cortex (V1) was used as the control region
[Amunts et al., 2000]. Reported voxel coordinates corre-
spond to standardized Montreal Neurologic Institute
space. To assess for correlations with mood, PANAS-X
scores were correlated with data extracted from regions of
group difference (averaged across the entire cluster).
RESULTS
Participants
Sixteen participants were administered pregnenolone, 14
were administered DHEA, and 15 were administered pla-
cebo. Groups did not differ by age [F(2,44)5 0.71, P5 0.5].
Pregnenolone administration significantly increased serum
pregnenolone, pregnanolone, and allopregnanolone levels,
and DHEA administration increased serum DHEA,
DHEAS, and androsterone levels (P< 0.001; details can be
found in Sripada et al. [2013a,b]). There were no signifi-
cant differences in subjective drug effects (P> 0.4), and
participants’ guesses of which drug they received did not
deviate from chance [v2(6)5 3.80, P5 0.7]. There were no
significant differences between drug administration and
placebo groups in self-reported sedation (P> 0.5).
Motion and Physiological Variables
There were no movements greater than 3 mm and no
motion differences between DHEA and placebo groups
(P> 0.2). In the pregnenolone administration group, mean
displacement was reduced (mean5 0.066 mm) when com-
pared with the placebo group (mean5 0.099 mm,
P5 0.006). To correct for this discrepancy, we imple-
mented motion scrubbing procedures. There were no
group differences in heart rate or respiration (P> 0.7).
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fMRI Findings
Under the placebo condition, the left amygdala seed
showed positive connectivity with right amygdala, peri-
amygdala, bilateral hippocampus and superior temporal
gyrus, and anti-correlations with posterior cingulate cortex
(see Table I). The right amygdala seed showed positive
connectivity with left amygdala, bilateral periamygdala
and bilateral hippocampus, and anti-correlation with pre-
cuneus (see Table I).
When compared with placebo, pregnenolone administra-
tion reduced connectivity between the left amygdala seed
and a cluster encompassing dmPFC and precuneus (see
Table II and Fig. 1). Pregnenolone also reduced connectiv-
ity between the right amygdala seed and left hippocampus
(see Fig. 1).
When compared with placebo, DHEA reduced connec-
tivity between the left amygdala seed and a cluster encom-
passing left amygdala, left periamygdala, and left insula
(see Table II and Fig. 2). There were no significant differ-
ences between DHEA and placebo groups in connectivity
with the right amygdala seed.
We also conducted an exploratory analysis of differences
in amygdala functional connectivity between pregnenolone
and DHEA administration groups. When compared with
DHEA, pregnenolone reduced functional connectivity
between left amygdala and dmPFC (see Table II).
Correlations with PANAS-X
When compared with placebo, DHEA administration
reduced PANAS-X negative affect score at trend level
[t(27)5 1.87, P5 0.07], as reported in Sripada et al. [2013a].
To probe the neural underpinnings of this effect, correla-
tions were computed between PANAS-X negative affect
score and the values extracted from regions of group dif-
ference. These included (1) the dmPFC and precuneus-
encompassing cluster that exhibited reduced connectivity
with left amygdala in the pregnenolone group, (2) the left
hippocampus-encompassing cluster that exhibited reduced
connectivity with right amygdala in the pregnenolone
group, and (3) the left insula-encompassing cluster that
exhibited reduced connectivity with left amygdala in the
DHEA group. Across all three groups (pregnenolone,
DHEA, and placebo), there was a positive correlation
between PANAS-X negative affect score and functional
connectivity between right amygdala and the
TABLE I. Functional connectivity under Placebo
Contrast map and brain region Cluster size
MNI coordinates
Analysis (z)x y z
Left amygdala positive correlations under PBO
Superior temporal gyrus/left insula 8,153 227 27 229 7.28
Medial frontal gyrus 59 26 41 223 4.45
Right lingual gyrus 13 15 240 22 4.29
Right Heschl’s gyrus 16 39 225 7 3.92
Inferior frontal gyrus 178 248 11 28 3.83
Right insula 14 30 27 10 3.71
Left angular gyrus 51 257 270 25 3.48
Left amygdala negative correlations under PBO
Right middle frontal gyrus 52 36 47 13 4.12
Posterior cingulate cortex 13 6 243 22 3.61
Right amygdala positive correlations under PBO
Right parahippocampal gyrus 1,935 24 210 223 7.66
Superior temporal gyrus 1,766 233 24 229 6.31
Right inferior temporal gyrus 13 48 249 226 5.37
Left inferior temporal gyrus 436 254 267 25 4.71
Right precentral gyrus 1,015 60 24 46 4.09
Left precentral gyrus 19 248 27 25 3.99
Inferior parietal lobule 23 248 234 49 3.84
Supplementary motor area 58 12 222 52 3.79
Right paracentral lobule 14 6 240 67 3.64
Left paracentral lobule 35 29 231 73 3.61
Right amygdala negative correlations under PBO
Cingulate gyrus 71 23 219 25 4.27
Precuneus 111 12 264 31 3.98
Left precuneus 12 29 270 34 3.38
MNI, Montreal Neurologic Institute; PBO, placebo.
Data thresholded at P< 0.001, uncorrected, extent threshold k5 10.
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hippocampus-encompassing cluster (r5 0.294, P5 0.05),
indicating that reduced connectivity with hippocampus
was associated with less negative affect. Across the
groups, there was also a positive correlation between
PANAS-X negative affect score and functional connectivity
between left amygdala and the insula-encompassing
TABLE II. Group comparisons
Contrast map and brain region Cluster size
MNI coordinates
Analysis (z)x y z
Left amygdala ALLO>placebo
Left superior frontal gyrus 2,687 29 228 76 3.84
Superior medial frontal gyrus (dmPFC) 196 212 41 37 2.82
Precuneus 199 29 240 55 2.86
Right amygdala ALLO>placebo
Left middle temporal gyrus 1,522 245 219 211 3.91
Left hippocampus 18 236 216 211 2.84
Left amygdala DHEA>placebo
Left supramarginal gyrus 2,038 266 2 7 3.62
Left insula 165 236 21 28 2.81
Left amygdala 8 224 27 214 2.40
Left amygdala DHEA>ALLO
Medial frontal gyrus 2,049 215 50 10 3.88
dmPFC 396 212 53 10 3.58
ALLO, allopregnanolone; dmPFC, dorsal medial prefrontal cortex; MNI, Montreal Neurologic Institute.
Cluster-level significance set at P< 0.05, whole brain corrected for multiple comparisons. Within each significant cluster, Z-score and
associated a priori region are noted along with MNI atlas coordinates of peaks in boldface.
Figure 1.
(a) Pregnenolone administration reduced functional connectivity
between left amygdala and a cluster encompassing dmPFC and
precuneus (x5211). (b) Pregnenolone administration reduced
functional connectivity between right amygdala and left hippocam-
pus (y5216). Bar graphs depict percent signal change. Error bars
depict standard error of the mean. dmPFC, dorsal medial prefron-
tal cortex; HPC, hippocampus. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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cluster (r5 0.291, P5 0.05). Additional correlations were
computed between PANAS-X negative affect score and the
values extracted from anatomical insula, dmPFC, hippo-
campus, and precuneus. Across all three groups (pregnen-
olone, DHEA, and placebo), there was a positive
correlation between PANAS-X negative affect score and
left amygdala functional connectivity with anatomical
precuneus (r5 0.319, P5 0.035).
Correlations with Neurosteroid Levels
To further probe relationships between neurosteroids
and connectivity patterns, correlations were computed
between delta serum neurosteroid levels (endpoint minus
baseline) and the values extracted from regions of group
difference. Across all three groups, functional connectivity
between the right amygdala seed and left hippocampus-
encompassing cluster was negatively associated with delta
serum pregnenolone (r520.513, P< 0.001), delta serum
pregnanolone (r520.326, P5 0.031), and delta serum allo-
pregnanolone (r520.553, P< 0.001). Across all three
groups, functional connectivity between the left amygdala
seed and left insula-encompassing cluster was negatively
associated with delta serum DHEAS (r520.436, P5 0.003)
and delta serum androsterone (r520.390, P5 0.009).
Additionally, functional connectivity between left amyg-
dala and anatomical left insula was negatively correlated
with delta serum DHEAS (r520.302, P5 0.047), and func-
tional connectivity between right amygdala and anatomi-
cal precuneus was negatively correlated with delta serum
pregnanolone (r520.301, P5 0.047). Neither pregneno-
lone nor DHEA significantly modulated connectivity
between amygdala and primary visual cortex (left amyg-
dala, P> 0.4; right amygdala, P> 0.7), indicating that drug
effects on other brain regions were not attributable to gen-
eral changes in the BOLD response.
DISCUSSION
To interrogate the neural underpinnings of anxiety- and
mood-altering properties of neurosteroids, we investigated
the impact of single-dose pregnenolone and DHEA on pat-
terns of resting-state functional connectivity of the amyg-
dala. When compared with placebo, pregnenolone
administration reduced connectivity between amygdala
and dmPFC, between amygdala and precuneus, and
between amygdala and hippocampus. When compared
with placebo, DHEA reduced amygdala connectivity with
insula and with periamygdaloid regions. These connectiv-
ity patterns were associated with less self-reported nega-
tive affect. To our knowledge, this is the first investigation
of resting-state functional connectivity after neurosteroid
administration and the first to demonstrate that neuroste-
roids modulate intrinsic connectivity networks in a way
that is relevant to negative affect. Our results demonstrate
that allopregnanolone and DHEA reduce connectivity
within the resting-state amygdala network and may also
shift the balance between intrinsic connectivity networks, a
function that could provide insight into the neurocircuitry
of anxiety psychopathology.
We found that DHEA reduced functional connectivity
within left amygdala and between left amygdala and left
periamygdala, suggesting reduced connectivity within this
emotion generation network. Converging evidence from
multiple lines of investigation suggests that higher anxiety
is associated with greater amygdala activity. Greater
amygdala activation is associated with greater state
[Bishop et al., 2004] and trait [Etkin et al., 2004] anxiety,
and a meta-analysis of neuroimaging studies in various
anxiety disorders concluded that elevated amygdala activ-
ity is present across anxiety disorders [Etkin and Wager,
2007]. Furthermore, both animal and human connectivity
data suggest that amygdala and extended amygdala func-
tion as a coordinated unit to process threat [Liberzon
et al., 2003; Oler et al., 2012]. It is still unclear, however, if
greater interamygdala connectivity is associated with
higher levels of anxiety. For example, Pantazatos et al.
[2012] have argued that right and left amygdala are more
coupled while viewing neutral faces than fearful faces.
However, given the strong link between amygdala activa-
tion and negative emotional response, it is reasonable to
interpret reduced interamygdala connectivity as poten-
tially contributing to reduced emotional reactivity. This
Figure 2.
DHEA reduced functional connectivity between left amygdala
and (a) periamygdala (y527) and (b) left insula (y5 4). Bar
graphs depict percent signal change. Error bars depict standard
error of the mean. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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reduction of connectivity within amygdala and between
amygdala and periamygdala may thus be relevant
DHEA’s anxiolytic effects [Maninger et al., 2009; Melchior
and Ritzmann, 1994].
DHEA administration also reduced functional connectiv-
ity between left amygdala and left insula. The insula is
implicated in interoception [Oppenheimer et al., 1992], dis-
gust [Britton et al., 2006], emotion processing [Stein et al.,
2007], emotional recall [Phan et al., 2002], and anticipation
of aversive stimuli [Simmons et al., 2008]. Amygdala and
insula are structurally interconnected [Aggleton et al.,
1980], and negative emotion induction enhances coupling
between insula and amygdala in healthy volunteers [van
Marle et al., 2010]. We have previously reported that
amygdala exhibits greater resting-state connectivity with
insula in patients with PTSD compared with healthy and
combat-exposed control participants [Sripada et al.,
2012a,b]. This finding has been replicated by others [Rabi-
nak et al., 2011]. Thus, reduced connectivity between
amygdala and insula could represent a protective/resil-
ience factor in the development of pathological anxiety
states. In support of this hypothesis, functional connectiv-
ity between amygdala and insula was positively associated
with negative affect in our sample. DHEA reduced connec-
tivity between amygdala and insula and also reduced
PANAS-X at trend level. However, given the lack of a stat-
istically significant decrease in PANAS-X scores, it is pos-
sible that the association between negative affect and
amygdala–insula connectivity may be due to spontaneous
variations in mood rather than a drug-induced effect.
During rest, the amygdala shows positive functional
connectivity with ventral medial prefrontal regions, insula,
thalamus, and striatum, and anticorrelations with superior
frontal gyrus, bilateral middle frontal gyrus, posterior cin-
gulate cortex, and precuneus [Fulwiler et al., 2012; Kim
et al., 2011; Roy et al., 2009]. Notably, the observed amyg-
dala resting-state connectivity map shows substantial over-
lap with the salience network, an intrinsic connectivity
network responsible for detecting and orienting to salient
stimuli, and implicated in homeostatic regulation, intero-
ceptive, autonomic, and reward processing [Cauda et al.,
2011; Dosenbach et al., 2007; Seeley et al., 2007; Sridharan
et al., 2008]. Amygdala, along with dorsal anterior cingu-
late cortex, anterior insula/inferior frontal gyrus, and ven-
tral striatum, are key nodes in this network. Both
allopregnanolone and DHEA have demonstrated effects on
this circuit in neuroimaging studies. DHEA’s reduction of
amygdala to insula connectivity and interamygdala con-
nectivity suggests that this neurosteroid may modulate the
intrinsic connectivity of the salience network. During task-
based studies, there is preliminary evidence to suggest
that DHEA modulates anterior cingulate cortex [Alhaj
et al., 2006; Sripada et al., 2013a] and insula activity [Alhaj
et al., 2006] and that allopregnanolone influences activity
in amygdala [Ossewaarde et al., 2010a; van Wingen et al.,
2007, 2008] and ventral striatum [Ossewaarde et al.,
2010b], all components of the salience network. We have
previously suggested that stronger within-salience network
connectivity is associated with greater anxiety [Sripada
et al., 2012a,b]. In addition, both PTSD and major depres-
sive disorder were found to be associated with greater
salience network activity in recent meta-analyses [Hamil-
ton et al., 2012; Patel et al., 2012]. As elevations in neuro-
steroids have been associated with symptomatic
improvement in anxiety disorders [Rasmusson et al.,
2006], the observed reduction of intrasalience network con-
nectivity could suggest a potential mechanism for this anx-
iolytic effect.
Finally, pregnenolone reduced amygdala connectivity
with dmPFC, precuneus, and hippocampus. Across
groups, greater amygdala to precuneus connectivity was
associated with greater PANAS-X negative affect (10 items
assessing constructs of fear, hostility, guilt, and sadness)
[Watson and Clark, 1994], suggesting that a reduction in
this connectivity is associated with less negative affect. In
monkeys, the amygdala is structurally connected with dor-
sal precuneus [Leichnetz, 2001], ventral precuneus [Parvizi
et al., 2006], and dmPFC/dorsal anterior cingulate cortex
[Ghashghaei et al., 2007] and in humans, amygdala typi-
cally shows negative functional connectivity with the pre-
cuneus and dmPFC at rest [Roy et al., 2009; Zhang and Li,
2012]. This is consistent with the key roles of the dmPFC
and precuneus in the default network, a network that is
anticorrelated with salience network at rest [Fox et al.,
2005]. The default network is associated with stimulus-
independent, internally focused thought, including sponta-
neous cognition, autobiographical memory, prospection,
and mind wandering [Menon, 2011; Qin and Northoff,
2011; Spreng et al., 2009; Toro et al., 2008], thus this net-
work is active during nonstructured tasks such as resting
state. The current data suggest that allopregnanolone
might further reduce functional connectivity between
amygdala and default network, contributing to enhanced
segregation between default network and salience
network.
Recently, our group has proposed that decreased segre-
gation, that is, inappropriate connectivity between salience
network and default network, contributes to anxiety psy-
chopathology [Sripada et al., 2012b]. Among participants
with PTSD, we found that greater functional connectivity
between default network and salience network regions
was correlated with elevated PTSD symptoms [Sripada
et al., 2012b]. Similarly, enhanced cross-network connectiv-
ity between default network and thalamus (a node in sali-
ence network) has been observed in PTSD in a different
study [Yin et al., 2011]. Furthermore, enhanced connectiv-
ity between default network and amygdala predicted the
development of PTSD symptoms in acutely traumatized
individuals [Lanius et al., 2010], and enhanced connectiv-
ity between default network and insula was associated
with higher self-reported anxiety in a separate study [Den-
nis et al., 2011]. Precuneus exhibits greater connectivity
with amygdala in generalized anxiety [Strawn et al., 2012]
and panic disorder [Pannekoek et al., 2013a] and with
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anterior cingulate cortex (a key node in salience network)
in social anxiety disorder [Pannekoek et al., 2013b]. More-
over, in healthy controls, acute laboratory stress increases
amygdala resting-state connectivity with precuneus and
posterior cingulate cortex [Veer et al., 2011], although the
authors note that this connectivity pattern might indicate
healthy rather than pathologic recovery and adaptation in
the poststressor period. Another study in healthy individ-
uals demonstrated that viewing fearful when compared
with neutral faces enhanced amygdala to precuneus cou-
pling [Pantazatos et al., 2012]. Together, these data evince
a consistent pattern in which anxiety disorders or induc-
tion of anxiety is associated with reduced segregation
between salience network and default network. Thus, allo-
pregnanolone’s enhancement of segregation between
default network and salience network highlights the
potential contribution of this neurosteroid to the ameliora-
tion of anxiety.
Although both pregnenolone and DHEA reduced amyg-
dala intrinsic connectivity, pregnenolone exerted a greater
effect than DHEA on connectivity with medial prefrontal
regions. These differences may be due to differing mecha-
nisms of action. DHEA appears to have anxiolytic-like
actions [Maninger et al., 2009; Melchior and Ritzmann,
1994]; however, it demonstrates modest negative modula-
tion of GABA(A) receptors [Imamura and Prasad, 1998].
Thus, its anxiolytic-like actions in rodents may involve
other mechanisms. In contrast, allopregnanolone has very
pronounced effects at the GABA(A) receptor and decreases
GABA(A) receptor responses with 20-fold higher potency
than benzodiazepines and barbiturates [Majewska et al.,
1986]. Allopregnanolone’s greater GABAergic activity, in
combination with the greater wealth of evidence linking
allopregnanolone to amygdala modulation, may help to
explain the somewhat stronger modulation of amygdala
connectivity under allopregnanolone versus DHEA.
There are several limitations to this study. Limitations of
our sample include the fact that the number of partici-
pants in each group was relatively small, thus, our results
should be considered preliminary. Additionally, our sam-
ple consisted of healthy male individuals without mood or
anxiety disorder diagnoses. Thus, extrapolations to women
or to clinical populations should be made with caution.
The between-group design of our study does not allow for
a baseline comparison of functional connectivity. Thus, it
is difficult to determine whether between-group differen-
ces are solely due to the drugs administered or partially
due to natural variation. Future studies should implement
a crossover design to address this issue. Additionally, we
did not obtain baseline measurements of subjective nega-
tive affect, and therefore group differences in PANAS-X
score may also be partially attributable to natural varia-
tion. Limitations of our intervention include the fact that
we measured serum levels of allopregnanolone and
DHEA, and not CSF or brain levels. However, in animals,
neurosteroid levels are highly correlated [Kancheva et al.,
2011; Marx et al., 2006a]. Additionally, in the allopregna-
nolone manipulation, we administered pregnenolone, allo-
pregnanolone’s precursor. Although we have framed our
results in terms of an allopregnanolone manipulation, it is
possible that our results may be attributable to increases in
pregnenolone in addition to allopregnanolone. As allo-
pregnanolone is not commercially available for clinical
use, it was necessary to administer pregnenolone as a pre-
cursor loading strategy to increase downstream allopreg-
nanolone levels, and our results demonstrate that oral
administration of pregnenolone increases allopregnanolone
levels sevenfold [see Sripada et al., 2013b]. We also did
not measure levels of additional downstream steroids.
Pregnenolone administration may increase levels of preg-
nenolone sulfate and progesterone [Marx et al., 2009], and
DHEA administration may increase estradiol and testoster-
one [Schmidt et al., 2005]. Thus, it is possible that increases
in these downstream steroids, rather than increases in only
allopregnanolone and DHEA, contributed to the reported
findings. Furthermore, although the bulk of DHEA
research supports an anxiolytic effect for DHEA, some
studies suggest an anxiogenic role [e.g., Dmitrieva et al.,
2001; van Goozen et al., 2000]. Thus, further studies should
assess the behavioral impact of DHEA’s reduction of
amygdala resting-state functional connectivity.
Turning to methodological limitations, our results may
have been impacted by the reduced average head displace-
ment of 0.03 mm in the pregnenolone group. For instance,
Van Dijk et al. [2012] have suggested that small head move-
ments can inflate measures of local functional coupling and
deflate measure of long-range functional coupling. How-
ever, we implemented scrubbing procedures as described
by Power et al. [2012], which have been demonstrated to
significantly reduce confounds introduced by head move-
ment. In addition, it has been reported that DHEA and
pregnenolone may potentially impact neurovascular cou-
pling [e.g., see Liu and Dillon, 2004; Naylor et al., 2010].
PET or arterial spin labeling studies could examine this
issue directly; however, we compared BOLD signal across
treatment groups in control regions (i.e., visual cortex) and
found no significant differences. Another potential limita-
tion is that different methodologies were used for assaying
different neurosteroids: GC/MS for pregnenolone and allo-
pregnanolone, and enzyme immunoassay for DHEA and
DHEAS. DHEA values derived from these two assay meth-
ods, however, show excellent correlation [Stanczyk, 2006],
and immunoassay is much less labor-intensive and less
expensive than GC/MS. In contrast, there are currently no
commercially available methodologies for allopregnanolone
and pregnenolone that approach the sensitivity and speci-
ficity of GC/MS, and it remains the “gold-standard” quan-
tification approach for these steroids. It also does not
appear optimal to use GC/MS for sulfated neurosteroids
such as DHEAS, given recent challenges and controversies
regarding their quantification [see Ebner et al., 2006; Higa-
shi et al., 2003; Liere et al., 2004; Liu et al., 2003; Marx et al.,
2009; Schumacher et al., 2008]. Finally, we have conceptual-
ized decreased within-salience network connectivity
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as relevant to reduced anxiety; however, decreased connec-
tivity within this network may also have drawbacks. For
instance, stronger salience network connectivity has been
associated with better working memory [Li et al., 2012].
Future studies should investigate neurosteroid modulation
of salience network in anxiety-disordered populations to
further assess the benefits and disadvantages of these
patterns.
CONCLUSION
In summary, allopregnanolone and DHEA reduced
amygdala functional connectivity with other regions
within amygdala/salience network and reduced amygdala
connectivity with regions of default network in our partici-
pants. These findings suggest that neurosteroids modulate
amygdala functional connectivity during the resting state
and may shift the balance between salience network and
default network at rest. These findings provide insight
into the neurocircuitry of anxiety and suggest that allo-
pregnanolone and DHEA may be potential targets for
pharmacological intervention for anxiety psychopathology.
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